NCT02610010View on ClinicalTrials.gov

Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2025

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

Cisplatin

Cisplatin 100 mg/m² every 3 weeks for 3 cycles during radiotherapy.

RADIATION

Intensity-modulated radiotherapy

Intensity-modulated radiotherapy

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
collaborator

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

OTHER

collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

The First Affiliated Hospital of Guangdong Pharmaceutical University

OTHER

lead

Sun Yat-sen University

OTHER